Cannabis Law Report

JULY 12, 2019

This differs sharply from the conventional course of cannabis medicine, which is to use whole, clean plant extracts to treat epilepsy and to gradually discontinue use of conventional pharmaceuticals. An Israeli study of cannabis versus epilepsy, however, used natural extracts with a ratio of 20:1 CBD:THC.

Extraction 73

Extraction Pharmaceutical CBD Epilepsy 73

TheAnswerPage

JUNE 12, 2022

Has the use of a transdermal gel for regional and systemic delivery of CBD been evaluated for the treatment of epilepsy? A transdermal gel for regional and systemic delivery of CBD (Zynerba Pharmaceuticals) is in clinical development for treatment of epilepsy, developmental and epileptic encephalopathy, fragile-X syndrome, and osteoarthritis.

Epilepsy 52

Epilepsy Topical Safety Treatment 52

Cannabis Law Report

SEPTEMBER 20, 2021

–(BUSINESS WIRE)– #pharma — Virpax ® Pharmaceuticals, Inc. Nanomerics”) to use Nanomeric’s molecular envelope platform technology (MET) for the nasal delivery of a cannabidiol (CBD) for the management of epilepsy in adults and children. About Virpax Pharmaceuticals.

Epilepsy 52

Epilepsy Research and Development Clinical Trials Chronic Pain 52

Cannabis Law Report

NOVEMBER 15, 2021

–(BUSINESS WIRE)– #earnings — Virpax ® Pharmaceuticals, Inc. Finally, we recently acquired the worldwide rights to VRP324, which is an intranasal pharmaceutical-grade cannabidiol product candidate for the management of epilepsy in children (rare pediatric disease) and adults. About Virpax Pharmaceuticals.

Pharmaceutical 52

Pharmaceutical Research and Development Clinical Trials Chronic Pain 52

TheAnswerPage

OCTOBER 11, 2021

Has the use of a transdermal gel for regional and systemic delivery of CBD been evaluated for the treatment of epilepsy? A transdermal gel for regional and systemic delivery of CBD (Zynerba Pharmaceuticals) is in clinical development for treatment of epilepsy, developmental and epileptic encephalopathy, fragile-X syndrome, and osteoarthritis.

Epilepsy 52

Epilepsy Topical Safety Treatment 52

Marijuanally

AUGUST 30, 2018

CBD is a hot topic these days. The FDA recently approved a CBD-based drug to help treat childhood epilepsy such as Dravet’s Syndrome which is difficult to treat with conventional pharmaceuticals. The post Hemp-derived CBD Vs Cannabis-derived CBD in topicals appeared first on MARIJUANALLY. Which one is better?

Topical 40

Topical Hemp CBD Cannabinoids 40

Cannabis Law Report

JULY 2, 2021

Dr. Rungpetch Sakulbumrungsilp Dean of the Faculty of Pharmaceutical Sciences, Chulalongkorn University. Dr. Rungpetch Sakulbumrungsilp, Dean of the Faculty of Pharmaceutical Sciences, Chulalongkorn University, unlike the present in which many facets and aspects of cannabis are being studied in addition to the work of Chula C.A.N.S.,

Research and Development 105

Research and Development Pharmaceutical Extraction Seed-To-Sale 105

MMJ Recs

JANUARY 6, 2024

From tinctures and edibles to topicals and inhalables, the variety of options can be overwhelming. Topicals , in the form of creams, balms, or patches, target localized pain or inflammation without inducing psychoactive effects. Capsules and pills provide a familiar oral ingestion method, akin to traditional pharmaceuticals.

Chronic Pain 52

Chronic Pain Topical Marijuana Indica 52

Project CBD

FEBRUARY 28, 2023

5 In June 2018, the FDA approved Epidiolex® (GW Pharmaceuticals; Cambridge, UK), the first FDA-approved pharmaceutical drug to contain a “purified drug substance [CBD] derived from marijuana,” for the treatment of seizures associated with two rare epilepsy disorders. Epilepsy Behav. Accessed October 17, 2022. 2021.108514.

CBD 144

CBD Seed-To-Sale Food Access 144

Cannabis Law Report

JANUARY 18, 2022

–(BUSINESS WIRE)– #pharma — Virpax ® Pharmaceuticals, Inc. About Virpax Pharmaceuticals. Epoladerm™ is a topical diclofenac spray film formulation being developed to manage osteoarthritis pain. Well-tolerated with No Serious Adverse Findings. BERWYN, Pa.–(BUSINESS Mack, Chairman and CEO of Virpax.

Safety 52

Safety Chronic Pain Research and Development Pharmaceutical 52

Cannabis Law Report

SEPTEMBER 6, 2021

GW Pharmaceuticals. GW Pharmaceuticals. Key Topics Covered: 1 Preface. Key Topics Covered: 1 Preface. Looking forward, the publisher expects the global medical cannabis market to grow at a CAGR of 15.3% during 2021-2026. Companies Mentioned. Canopy Growth Corporation. Aurora Cannabis Inc. Aphria Inc. Companies Mentioned.

Chronic Pain 86

Chronic Pain Research and Development Clinical Trials Epilepsy 86

Cannabis Law Report

JULY 9, 2021

Oftentimes people choose to use CBD oils that can be taken orally or applied topically, however, when regularly buying CBD oils the cost can soon add up so some people choose to check out this page to get discounts and advice on the most suitable CBD products for them. Alleviation of Neurological Problems. Relief from Symptoms of Cancer.

Blood Pressure 105

Blood Pressure CBD Pets Oil 105

Cannabis Law Report

DECEMBER 20, 2021

–(BUSINESS WIRE)– #pharma — Virpax ® Pharmaceuticals, Inc. About Virpax Pharmaceuticals. Epoladerm™ is a topical diclofenac spray film formulation being developed to manage osteoarthritis pain. First Patient Expected to be Enrolled by Q2 of 2022. Data To Support Regulatory Filings in the United States.

Clinical Trials 52

Clinical Trials Chronic Pain Pharmaceutical Data 52

MGC Pharma

FEBRUARY 20, 2018

The Top Medical Cannabis Research of 2017 A word from Ron Lipsky, Manager of Business Development and International Relations at MGC Pharmaceuticals MGC Pharma is still riding off the success of 2017 as we progress into 2018, with many exciting developments on the horizon.

Research and Development 100

Research and Development Clinical Trials Patients Chronic Pain 100

Cannabis Law Report

DECEMBER 8, 2021

–(BUSINESS WIRE)– #pharma — Virpax ® Pharmaceuticals, Inc. About Virpax Pharmaceuticals. Epoladerm™ is a topical diclofenac spray film formulation being developed to manage osteoarthritis pain. BERWYN, Pa.–(BUSINESS The results of this study underscore the safety of our spray film technology.”.

Clinical Trials 52

Clinical Trials Chronic Pain Pharmaceutical Topical 52

Canna Law Blog

APRIL 27, 2020

Some related topics we’ve written on are CBD comestibles , CBD pet products , CBD in alcohol , and CBD topicals. We’ve also written about the enforcement actions issued by the FDA to CBD companies, including those issued to CBD companies selling topical products, and on April 23, 2020, the FDA announced its latest round of enforcement.

CBD 59

CBD Topical Oil Treatment 59

Kind Meds (Cannabis Education Blog)

NOVEMBER 18, 2020

For example, many anti-anxiety pharmaceuticals are habit-forming, entail significant negative side effects, and can also cause physical problems such as diminished mobility or coordination. CBD is also available in conventional pill and tablet form, as a base to use for cooking, and in topical products. CBD for Anxiety.

Treatment 111

Treatment Conditions CBD Clinical Trials 111

NORML

AUGUST 26, 2019

There are currently five “pharmaceutical processor” permit holders in Virginia, and they’re about to open for business. These were moms and dads and grandparents of children [with intractable epilepsy] who were using medical cannabis oils. As in, no to anyone who wasn’t an epilepsy patient.].

Marijuana 208

Marijuana Legalization Programs Oil 208

Kind Meds (Cannabis Education Blog)

JANUARY 9, 2019

Medical marijuana laws have changed dramatically across the country in recent years, and now cannabis pharmaceuticals appear to be the next big leap forward in cannabis law reform. Epidiolex has received FDA approval to treat Dravet Syndrome and Lennox-Gestaut Syndrome; two very rare forms of epilepsy that manifest in early childhood.

Research and Development 97

Research and Development Treatment Pharmaceutical Conditions 97

CannaTech

JANUARY 16, 2019

Pharmaceutical grade cannabis is relatively new in parts of the world. This statistic accounts for medicines treating patients with epilepsy, anxiety, depression, chronic pain, and other illnesses. This article has primarily offered a small dose of the pharmaceutical side of the medical cannabis market in Latin America.

Access 89

Access Patients Pharmaceutical Education 89

Cannabis Law Report

JANUARY 10, 2022

This high share is attributable to the rising adoption of THCV for various applications such as epilepsy, arthritis, metabolic disorders, neurological disorders, and pain management. For instance, as of June 2021, InMed Pharmaceuticals, Inc., Key Topics Covered: Chapter 1 Methodology and Scope. Market Segmentation and Scope.

Cannabinoids 52

Cannabinoids Clinical Trials Research and Development Supply Chain 52

Cannabis Law Report

OCTOBER 1, 2021

–(BUSINESS WIRE)– #pharma — Virpax ® Pharmaceuticals, Inc. Additionally, a video webcast of the presentation will be available beginning October 7, 2021 on the Investors section of the Virpax Pharmaceuticals website at [link]. About Virpax Pharmaceuticals. BERWYN, Pa.–(BUSINESS

Research and Development 52

Research and Development Pharmaceutical Clinical Trials Chronic Pain 52

Leaf Science

JULY 23, 2019

In the UK, cannabis was legalized for medicinal purposes in 2018 which saw patients of epilepsy and multiple sclerosis able to access pharmaceutical cannabis derivatives such as Sativex and Epidiolex. We shall look into what these benefits may be and what the science do we have that backs this up.

Strains 74

Strains Cannabinoids Epilepsy THC 74

The Cannigma

JUNE 15, 2021

The first clinical research done on CBD as a potential treatment for epilepsy was in 1980, but the information gleaned didn’t make its way to the public eye until decades later. The perception that CBD is a wonder-drug version of cannabis — particularly known for its uses to treat epilepsy — that doesn’t get you high. Shutterstock).

CBD 122

CBD Research and Development Epilepsy Extraction 122

Cannabis Law Report

OCTOBER 6, 2021

With the additional funding recently secured by Virpax and the strengthening of our balance sheet, we are continuing to advance our product candidates and to move them through preclinical studies and into human clinical trials,” said Anthony Mack, Chairman and Chief Executive Officer of Virpax Pharmaceuticals. About Virpax Pharmaceuticals.

Research and Development 52

Research and Development Clinical Trials Pharmaceutical Chronic Pain 52

Cannabis Law Report

SEPTEMBER 9, 2021

Medical cannabis is used for the treatment of various chronic conditions, such as Parkinson’s disease, Alzheimer’s disease, arthritis, cancer, depression, anxiety, epilepsy, and other neurological conditions. Key Topics Covered: Chapter 1 Methodology and Scope. GW Pharmaceuticals, PLC. Chapter 2 Executive Summary.

Recreational 95

Recreational Hemp THC Legalization 95

Veriheal

SEPTEMBER 22, 2021

As per the proposed bill, multiple sclerosis (MS), Parkinson’s disease , epilepsy , post-traumatic stress disorder (PTSD), and HIV/AIDS are some examples of medical conditions featured on the list of qualifying criteria. Home cannabis cultivation, on the other hand, would be forbidden.

Legalization 111

Legalization Patients Cultivation Legislation 111

The Cannigma

MARCH 7, 2022

When CBN was studied without barbiturates (prescription sedative medications typically used for epilepsy), the combination of CBN and THC produced greater sedation together than either cannabinoid alone. Those recruited will apply either CBN cream or placebo to non-wounded areas over a course of 28 days.

THC 140

THC Sleep Clinical Trials Cannabinoids 140

Cannabis Law Report

OCTOBER 20, 2019

She is currently a law school professor teaching Marijuana and the Law at California Western School of Law and researcher under a contract with NHTSA and NORC on the topic of the prosecution of drugged driving cases. xi] “Pharmaceutical Research and Manufacturers of America (PhRMA) spent $19.7 as a Schedule II substance.

Marijuana 45

Marijuana Pharmaceutical Chronic Pain Research and Development 45

Cannabis Law Report

NOVEMBER 10, 2021

–(BUSINESS WIRE)– #pharma — Virpax ® Pharmaceuticals, Inc. About Virpax Pharmaceuticals. Epoladerm™ is a topical diclofenac spray film formulation being developed to manage osteoarthritis pain. Virpax is initially seeking FDA approval of its three patented drug delivery platforms.

Research and Development 52

Research and Development Chronic Pain Pharmaceutical Clinical Trials 52

Cannabis Law Report

SEPTEMBER 28, 2021

Topical Creams. CBD oil and other products containing this cannabinoid are used to treat a number of health conditions, including chronic pain, inflammation, mood disorders, epilepsy, osteoporosis, and diabetes. Acupressure is an alternative method to treat pain without using pharmaceuticals. CBD Products. Acupressure.

Treatment 52

Treatment Chronic Pain Therapy Tincture 52

Cannabis Law Report

FEBRUARY 3, 2022

The presence of major key players, pharmaceutical and biotechnology industries worldwide, and their experimental approach drives the cannabis market growth. Based on route of administration, the market is segmented into oral, topical, inhalation, rectal, sublingual. Gw Pharmaceuticals plc. Medical Marijuana Inc. Cv Sciences Inc.

Indica 52

Indica Oil Legalization Research and Development 52

Alchimia

JANUARY 4, 2016

The three most populated Australian States (Victoria, New South Wales, Queensland) promised to organize studies on the efficiency of cannabis to alleviate terminally ill patients, controlling severe epilepsy in children, as well as for the treatment of side effects of chemotherapy. Source: The Guardian ). Source: SIPSE.COM ). t be denied.

Marijuana 48

Marijuana Epilepsy Pharmaceutical Chronic Pain 48

Cannabis Law Report

JUNE 20, 2019

But, some patients often use pharmaceutical drugs to reduce symptoms of stress, depression, and anxiety. Multiple sclerosis and epilepsy. Some of them include Alzheimer’s disease, Parkinson’s disease, cancer, glaucoma, multiple sclerosis, epilepsy, anorexia, insomnia, and post-traumatic stress disorder, among others.

History 67

History Medicine Chronic Pain Conditions 67

PrestoDoctor

OCTOBER 13, 2023

However, unlike marijuana, Marinol is a FDA-approved pharmaceutical drug. While cannabis is still a controversial topic, Marinol has been approved by the FDA for specific medical uses. Medical cannabis consumption has various methods , including smoking, vaping, edibles, oils, and topicals.

THC 98

THC Chronic Pain Treatment Conditions 98

Alchimia

JUNE 20, 2016

That could explain why kids using CBD to treat epilepsy may experience some of the side effects of THC, like sleepiness. Topical application is particularly efficient to treat localized pains or skin problems like acne or psoriasis. CBD crystals , 98% purity. Cannabidiol can also be used via CBD creams, ointments and other compounds.

Medicine 76

Medicine CBD Research and Development Epilepsy 76

Miss Marijuana

MAY 17, 2020

Mental health is a more relevant topic than ever before, and cannabis may be an effective natural option for those looking to manage their well-being. Most participants experienced little to no side effects, which is great news for those looking for alternatives to pharmaceuticals to treat anxiety and depression. .

Marijuana 52

Marijuana Sleep Treatment Chronic Pain 52